Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan C Oosterwijk

Showing results (41-50 of 95) with videos related to

Pageof 10
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 24, 2014
Bone mineral density and fractures after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancerIngrid E Fakkert, Elske Marije Abma, Iris G Westrik, et al.
Journal of the National Cancer Institute|August 14, 2013
Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imagingSepideh Saadatmand, Madeleine M A Tilanus-Linthorst, Emiel J T Rutgers, et al.
The Journal of Investigative Dermatology|September 18, 2004
Novel types of mutation responsible for the dermatosparactic type of Ehlers-Danlos syndrome (Type VIIC) and common polymorphisms in the ADAMTS2 geneAlain Colige, Lieve Nuytinck, Ingrid Hausser, et al.
Journal of Medical Genetics|June 13, 2019
Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-<i>BRCA1/2</i> breast cancer familiesInge M M Lakeman, Florentine S Hilbers, Mar Rodríguez-Girondo, et al.
International Journal of Cancer|January 8, 2013
Optimal age to start preventive measures in women with BRCA1/2 mutations or high familial breast cancer riskMadeleine M A Tilanus-Linthorst, Hester F Lingsma, D Gareth Evans, et al.
European Journal of Cancer (Oxford, England : 1990)|June 28, 2005
Hereditary breast cancer growth rates and its impact on screening policyMadeleine M A Tilanus-Linthorst, Mieke Kriege, Carla Boetes, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 10, 2016
Bias Explains Most of the Parent-of-Origin Effect on Breast Cancer Risk in BRCA1/2 Mutation CarriersJanet R Vos, Jan C Oosterwijk, Cora M Aalfs, et al.
European Journal of Human Genetics : EJHG|February 28, 2018
The association between cancer family history and ovarian cancer risk in BRCA1/2 mutation carriers: can it be explained by the mutation position?Natalia Teixeira, Annemieke van der Hout, Jan C Oosterwijk, et al.
Human Mutation|July 31, 2010
Keratosis Follicularis Spinulosa Decalvans is caused by mutations in MBTPS2Emmelien Aten, Lisa C Brasz, Dorothea Bornholdt, et al.
Human Molecular Genetics|August 14, 2003
The HLA class III subregion is responsible for an increased breast cancer riskMirjam M de Jong, Ilja M Nolte, Elisabeth G E de Vries, et al.
Pageof 10

Showing results (41-50 of 95) with videos related to

Sort By:
Pageof 10
European Journal of Cancer (Oxford, England : 1990)|December 24, 2014
Bone mineral density and fractures after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancerIngrid E Fakkert, Elske Marije Abma, Iris G Westrik, et al.
Journal of the National Cancer Institute|August 14, 2013
Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imagingSepideh Saadatmand, Madeleine M A Tilanus-Linthorst, Emiel J T Rutgers, et al.
The Journal of Investigative Dermatology|September 18, 2004
Novel types of mutation responsible for the dermatosparactic type of Ehlers-Danlos syndrome (Type VIIC) and common polymorphisms in the ADAMTS2 geneAlain Colige, Lieve Nuytinck, Ingrid Hausser, et al.
Journal of Medical Genetics|June 13, 2019
Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-<i>BRCA1/2</i> breast cancer familiesInge M M Lakeman, Florentine S Hilbers, Mar Rodríguez-Girondo, et al.
International Journal of Cancer|January 8, 2013
Optimal age to start preventive measures in women with BRCA1/2 mutations or high familial breast cancer riskMadeleine M A Tilanus-Linthorst, Hester F Lingsma, D Gareth Evans, et al.
European Journal of Cancer (Oxford, England : 1990)|June 28, 2005
Hereditary breast cancer growth rates and its impact on screening policyMadeleine M A Tilanus-Linthorst, Mieke Kriege, Carla Boetes, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 10, 2016
Bias Explains Most of the Parent-of-Origin Effect on Breast Cancer Risk in BRCA1/2 Mutation CarriersJanet R Vos, Jan C Oosterwijk, Cora M Aalfs, et al.
European Journal of Human Genetics : EJHG|February 28, 2018
The association between cancer family history and ovarian cancer risk in BRCA1/2 mutation carriers: can it be explained by the mutation position?Natalia Teixeira, Annemieke van der Hout, Jan C Oosterwijk, et al.
Human Mutation|July 31, 2010
Keratosis Follicularis Spinulosa Decalvans is caused by mutations in MBTPS2Emmelien Aten, Lisa C Brasz, Dorothea Bornholdt, et al.
Human Molecular Genetics|August 14, 2003
The HLA class III subregion is responsible for an increased breast cancer riskMirjam M de Jong, Ilja M Nolte, Elisabeth G E de Vries, et al.
Pageof 10